Work

Effect of inducing HR deficiency using AVB500, a receptor tyrosine kinase AXL inhibitor, on response to olaparib in uterine serous cancer.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.e18108

Authors: Michael Driscoll Toboni, Barbara Blachut, Mary M Mullen, Jo'an Tankou, Hollie M Noia, Alyssa Oplt, Danny Wilke, Lindsay M Kuroki, Andrea R. Hagemann, Carolyn K McCourt, Premal H. Thaker, David Gardner Mutch, Matthew A. Powell, Katherine Cynthia Fuh

Institutions: Barnes-Jewish Hospital, Washington University in St. Louis

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3028997347

Cites:

Cited by:

Related to: 10